You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis

详细信息    查看全文

• 作者：Xiaomin Ji ; Haolong Liu ; Chen An ; Yongqiang Wang ; Hui Zhao ; Qiuxia Zhang ; Ming Li ; Fang Qi ; Zhenzhen Chen ; Xiujuan Wang ; ^{wxj0517@sina.com" class="auth_mail" title="E-mail the corresponding author} ; Lei Wang ; ^{tmwangl@ccmu.edu.cn" class="auth_mail" title="E-mail the corresponding author}
• 关键词：YGPs ; You-Gui pills ; EAE ; experimental autoimmune encephalomyelitis ; MS ; multiple sclerosis ; DCC ; deleted in colorectal cancer ; GTPases ; guanosine triphosphatases ; MOG ; myelin oligodendrocyte glycoprotein ; MAP ; microtubule-associated protein ; IHC ; immunohistochemistry ; qRT-PCR ; real-time quantitative polymerase chain reaction ; WB ; Western blot ; PI ; post-immunization ; CNS ; central nervous system ; BDNF ; brain-derived neurotrophic factor ; CFA ; complete Freund's adjuvant ; PTX ; pertussis toxin ; PA ; p
• 刊名：Journal of Ethnopharmacology
• 出版年：2016
• 出版时间：1 July 2016
• 年：2016
• 卷：187
• 期：Complete
• 页码：123-133
• 全文大小：3543 K

文摘

You-Gui pills (YGPs) are an effective traditional Chinese formula being used clinically for the treatment of multiple sclerosis (MS). Previous studies demonstrated that YGPs exerted the potent neuroprotective effects in murine models of experimental autoimmune encephalomyelitis (EAE), which is an equivalent animal model for multiple sclerosis (MS). However, the mechanism of YGPs functions remained unclear.

Aim of this study

The aim of this study was to evaluate the therapeutic effect of YGPs in MOG_35–55-induced EAE mice and to further elucidate the underlying molecular mechanism. Methods: Female C57BL/6 mice were divided into six groups, including the non-treated EAE model, prednisone acetate- and 1.2, 2.4 or 4.8 g/kg YGPs-treated EAE groups, and a normal control group. The EAE model was established by injecting the mice subcutaneously with MOG_35–55 antigen. The body weights were measured and the neurological functions were scored in each group. The pathology and morphology of the brain and spinal cord was examined. The expression of MAP-2 was detected by immunofluorescent staining. The levels of netrin1, DCC, RhoA, Rac1, and Cdc42 were assayed by immunohistochemistry, qRT-PCR and Western blot on day 40 post-immunization (PI).

Results

YGPs treatments significantly reduced neurological function scores in EAE mice, where the inflammatory infiltration was reduced and the axon and myelin damage in both brain and spinal cord was alleviated. In the brain and spinal cord tissues, YGPs increased the expression of neuronal factors MAP-2, netrin1 and DCC. The expression of Rac1 and Cdc42 were increased, while RhoA was reduced following YGPs treatments.

Conclusion

Our results demonstrated that YGPs exhibited a neuroprotective effect on promoting nerve regeneration at the brain and spinal cord in EAE mice induced by MOG_35–55. Netrin1, DCC and the Rho family GTPases of RhoA, Racl, Cdc42 were involved in mediating the effects of YGPs on nerve regeneration.